RNAi mechanisms in Huntington’s disease therapy: siRNA versus shRNA
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
RNAi mechanisms in Huntington’s disease therapy: siRNA versus shRNA
Authors
Keywords
RNAi, shRNA, siRNA, Huntington’s disease, Off-target effects, Huntingtin, Silencing
Journal
Translational Neurodegeneration
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-11-10
DOI
10.1186/s40035-017-0101-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficient CNS targeting in adult mice by intrathecal infusion of single-stranded AAV9-GFP for gene therapy of neurological disorders
- (2017) K Bey et al. GENE THERAPY
- MR-guided parenchymal delivery of adeno-associated viral vector serotype 5 in non-human primate brain
- (2017) L Samaranch et al. GENE THERAPY
- Adeno-Associated Virus-Based Gene Therapy for CNS Diseases
- (2016) Michaël Hocquemiller et al. HUMAN GENE THERAPY
- Design, Characterization, and Lead Selection of Therapeutic miRNAs Targeting Huntingtin for Development of Gene Therapy for Huntington's Disease
- (2016) Jana Miniarikova et al. Molecular Therapy-Nucleic Acids
- Gene therapy returns to centre stage
- (2015) Luigi Naldini NATURE
- Alleviation of off-target effects from vector-encoded shRNAs via codelivered RNA decoys
- (2015) Stefan Mockenhaupt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Silencing Mutant Huntingtin by Adeno-Associated Virus-Mediated RNA Interference Ameliorates Disease Manifestations in the YAC128 Mouse Model of Huntington's Disease
- (2014) Lisa M. Stanek et al. HUMAN GENE THERAPY
- A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's disease
- (2014) Marianne R. Smith et al. HUMAN MOLECULAR GENETICS
- Targets for future clinical trials in Huntington's disease: What's in the pipeline?
- (2014) Edward J. Wild et al. MOVEMENT DISORDERS
- Systemic gene delivery to the central nervous system using Adeno-associated virus
- (2014) Mathieu Bourdenx et al. Frontiers in Molecular Neuroscience
- Immune Responses to AAV-Vectors, the Glybera Example from Bench to Bedside
- (2014) Valerie Ferreira et al. Frontiers in Immunology
- HDAC4 Reduction: A Novel Therapeutic Strategy to Target Cytoplasmic Huntingtin and Ameliorate Neurodegeneration
- (2013) Michal Mielcarek et al. PLOS BIOLOGY
- The AAV Vector Toolkit: Poised at the Clinical Crossroads
- (2012) Aravind Asokan et al. MOLECULAR THERAPY
- “Huntingtin Holiday”: Progress toward an Antisense Therapy for Huntington's Disease
- (2012) Xiao-Hong Lu et al. NEURON
- Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin Synthesis
- (2012) Holly B. Kordasiewicz et al. NEURON
- Ganglioside GM1 induces phosphorylation of mutant huntingtin and restores normal motor behavior in Huntington disease mice
- (2012) A. Di Pardo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Synthetic zinc finger repressors reduce mutant huntingtin expression in the brain of R6/2 mice
- (2012) M. Garriga-Canut et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PGC-1 Rescues Huntington's Disease Proteotoxicity by Preventing Oxidative Stress and Promoting TFEB Function
- (2012) T. Tsunemi et al. Science Translational Medicine
- Current progress of siRNA/shRNA therapeutics in clinical trials
- (2011) John C. Burnett et al. Biotechnology Journal
- Potent and Selective Antisense Oligonucleotides Targeting Single-Nucleotide Polymorphisms in the Huntington Disease Gene / Allele-Specific Silencing of Mutant Huntingtin
- (2011) Jeffrey B Carroll et al. MOLECULAR THERAPY
- Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
- (2011) Lydia Alvarez-Erviti et al. NATURE BIOTECHNOLOGY
- Kinase inhibitors modulate huntingtin cell localization and toxicity
- (2011) Randy Singh Atwal et al. Nature Chemical Biology
- Exploiting Nucleotide Composition to Engineer Promoters
- (2011) Manfred G. Grabherr et al. PLoS One
- Chemical Inducers of Autophagy That Enhance the Clearance of Mutant Proteins in Neurodegenerative Diseases
- (2010) Maurizio Renna et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Reduced seed region-based off-target activity with lentivirus-mediated RNAi
- (2010) R. A. Klinghoffer et al. RNA
- siRNA vs. shRNA: Similarities and differences
- (2009) Donald D. Rao et al. ADVANCED DRUG DELIVERY REVIEWS
- Comparative assessment of siRNA and shRNA off target effects: what is slowing clinical development
- (2009) D D Rao et al. CANCER GENE THERAPY
- Serines 13 and 16 Are Critical Determinants of Full-Length Human Mutant Huntingtin Induced Disease Pathogenesis in HD Mice
- (2009) Xiaofeng Gu et al. NEURON
- A Lentivirus-Mediated Genetic Screen Identifies Dihydrofolate Reductase (DHFR) as a Modulator of β-Catenin/GSK3 Signaling
- (2009) Richard A. Klinghoffer et al. PLoS One
- A Gene Network Regulating Lysosomal Biogenesis and Function
- (2009) Marco Sardiello et al. SCIENCE
- An Optimized Lentivirus-Mediated RNAi Screen Reveals Kinase Modulators of Kinesin-5 Inhibitor Sensitivity
- (2008) Richard A. Klinghoffer et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- Phosphorylation of mutant huntingtin at S421 restores anterograde and retrograde transport in neurons
- (2008) Diana Zala et al. HUMAN MOLECULAR GENETICS
- RNAi-mediated reversible opening of the blood-brain barrier
- (2008) Matthew Campbell et al. JOURNAL OF GENE MEDICINE
- Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: Implications for the therapeutic development of RNAi
- (2008) J. L. McBride et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The potential of intracellular antibodies for therapeutic targeting of protein-misfolding diseases
- (2008) Alessio Cardinale et al. TRENDS IN MOLECULAR MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now